 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol
IDs
|
|
|
| |
Study to Investigate the Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients With Bladder Cancer Undergoing Radical or Total Cystectomy
|
|
|
|
Phase III
|
|
|
|
12002
NCT00306150
|
|
| |
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
|
|
|
|
Phase II, Phase I
|
|
|
|
RTOG-0524
NCT00238420
|
|
| |
Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery
|
|
|
|
Phase II
|
|
|
|
MUSC-AVF-3312
100892, MUSC-HR-15537, GENENTECH-AVF-3312, NCT00268450, MUSC-CTO-100892
|
|
| |
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
|
|
|
|
Phase II
|
|
|
|
CINJ-3330
NCT00161187
|
|
| |
Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer
|
|
|
|
Phase II
|
|
|
|
UNC-LCCC-0521
LCCC 0521, NCT00380029
|
|
| |
Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer
|
|
|
|
Phase II
|
|
|
|
2006-0620
NCT00506155
|
|
| |
Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer
|
|
|
|
Phase II
|
|
|
|
UMCC 2007.061
NCT00585689
|
|
| |
Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer
|
|
|
|
Phase II
|
|
|
|
WCCC-UWI06-8-01
UWI06-8-01, CO06810, H2007-0250, 07-1270-03, NCT00666562
|
|
| |
Neoadjuvant Erlotinib (Tarceva) in Transitional Cell Carcinoma
|
|
|
|
Phase II
|
|
|
|
2007-0704
NCT00749892
|
|
| |
Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection
|
|
|
|
Phase II
|
|
|
|
MCC-15441
IRB 10718, NCT00751140
|
|
